138 - Virtual & Augmented Reality in Pharma (S10E3)

Welcome to the Deep Dive. Today we're taking
a really interesting plunge into virtual and
augmented reality, specifically how it's being
used in the pharmaceutical industry. Right. Now
you might be listening because maybe you've got
a meeting coming up or you're just trying to
get a handle on the latest tech in pharma. Or
maybe just curious, which is fair enough. Exactly.
Whatever the reason, our goal here is pretty
straightforward. Give you a clear, insightful
look at this area. without drowning you in jargon.
Yeah. We want to cut through the hype. Think
of this as a focused look at where VR and AR
are actually practically being applied in pharma
right now. We're going to hit, what, three main
areas? That's the plan. Based on the material
we've been digging into, we'll focus on training,
then simulation and design for processes and
facilities, and finally, visualizing those incredibly
complex molecular interactions. Super important
for drug discovery. Definitely. We're essentially
unpacking a detailed transcript that focuses
specifically on VR and AR in pharma. Our mission,
if you will, is to pull out the key stuff, use
examples where we can maybe even linking back
to things like OPR and D literature if it fits.
Right. Connect the dots a bit. And really understand
the practical side and maybe where this is all
heading. So the big takeaway we hope you get
is how these aren't just sci -fi concepts anymore.
They're becoming real tools shaping how medicines
get developed and made. Okay, ready to dive in.
Let's do it. All right. Let's start with training.
VR and AR in pharmaceutical training. That feels
like a pretty significant shift from, say, reading
manual. Oh, absolutely. It really is. I mean,
think about traditional pharma training. For
complex manufacturing or handling sensitive stuff,
it's always been tricky. Resource heavy, sometimes
risky. VR and AR offer something totally different.
Immersive interactive learning environments.
The transcript we looked at had some really good
examples. One that jumped out was simulating
complex manufacturing processes, like operating
specific equipment. It made me think that, you
know, we talked about that 100 -liter reactor
gelling issue before. from that season six transcript.
Right. The scale up problem. Imagine training
people on handling temperature controls or mixing
differently in VR before they face that for real.
That's a perfect example. It's exactly that kind
of scenario where VR shines. You get a safe space
to practice critical steps, maybe even tweet
parameters virtually. Without wasting a real
batch. Exactly. No real world risk, no cost.
If you mess up the virtual batch, you learn from
mistakes without actual consequences. That builds
real under... And it's not just the big process
stuff, is it? The transcript also mentioned VR
for aseptic technique training, like in a virtual
clean room. Yes, and that immediately connects
to, you know, all the GMP principles we've covered.
Clean facilities, personal hygiene, the stuff
from the GMP handbook. Crucial stuff. Absolutely
critical. In a real clean room, one contamination
event can be disastrous. VR lets trainees practice
gowning, sterile transfers, all those detailed
procedures over and over. With feedback, presumably.
Instantly. Immediate feedback in the virtual
world. And zero risk to an actual GMP suite.
So they can really hone those skills until they're
second nature. That massively cuts down contamination
risk later. Okay, that makes a lot of sense.
Another practical one mentioned was virtual walk
-throughs, facility layouts, emergency procedures.
Seems like a smart way to get people prepared.
It really does. Think about learning a whole
plant layout virtually. Finding emergency exits,
understand material flow, personnel flow, all
before you even set foot in the real building.
Reduces the getting -loss factor on day one.
And speeds up emergency response. Yeah. It reduces
errors just because people actually know where
things are. It's got to be more effective than
just, you know, staring at a 2D floor plan. Well,
the benefits seem clear from the transcript.
Engagement is a big one, right? Yeah. Let's face
it, reading SOPs or watching videos isn't always
thrilling. Not usually, no. VR and AR pull you
in. It's immersive, interactive, that naturally
helps people remember things better. You're doing
it, not just reading about it. That active involvement.
It makes a huge difference, creates a stronger
memory. Plus, think about standardizing training.
everyone across different sites, different teams,
gets the exact same high quality virtual training
experience. That's a good point. Consistency.
And I guess long term there have to be cost savings
too. Setting up physical training rigs, potential
mistakes with real expensive equipment or materials.
Definitely. The upfront investment in VR might
seem significant, but compared to the ongoing
costs of traditional training, potential batch
loss, equipment damage, it could pay off significantly
over time. Okay, so training is definitely a
strong area, but these tools go beyond just teaching
people existing stuff, right? What about using
them in like design and simulation? Yes, this
is where it starts impacting the actual development
and manufacturing setup. Not just training on
the process, but designing the process itself.
How so? The transcript mentioned visualizing
3D plant models before they're even built. Exactly.
Imagine engineers and scientists doing a virtual
walkthrough of a plant design. like the holodeck,
but for pharma plants. Sort of. But practical.
They can spot potential bottlenecks in workflow,
identify safety hazards, see if the layout is
actually efficient, all before a single brick
is laid. That sounds incredibly useful. Thinking
about those scale up problems again, maybe a
virtual walkthrough of the bigger facility design
could have caught some issues earlier. It absolutely
could have. Spotting potential clashes, space
constraints, inefficient movement paths. Doing
that virtually saves enormous amounts of time
and money compared to fixing it after construction.
Makes perfect sense. What about augmented reality
in existing places, not just virtual designs?
AR plays a big role there, too. It's about overlaying
digital info onto the real world. So a technician
looking at a machine. Through glasses or a tablet?
Right. They can see real -time data, maybe step
-by -step repair instructions, or quality check
prompts overlaid right onto the equipment. Wow,
like having digital notes appear exactly where
you need them. Pretty much. That could boost
efficiency, definitely cut down on errors in
manufacturing or lab work. It gives people the
critical info they need right when and where
they need it. It ties directly into managing
those key process parameters and quality attributes
we always talk about. Yeah, I can see that. The
transcript also hinted at using VR for designing
drug delivery devices. That seems a bit different.
It is, but think about designing an inhaler or
an auto injector. User friendliness is key for
patients, right? Absolutely. Compliance depends
on it. So VR lets designers make virtual prototypes.
They can simulate how a patient might actually
use it, test different button placements, different
interfaces, even get virtual user feedback really
early on. Before making expensive physical prototypes.
Exactly. leading to better, more intuitive devices
in the end, hopefully improving patient outcomes.
Okay, so training, facility design, equipment
interaction, even device design? These tools
are getting integrated pretty broadly. Let's
shift gears again, though, to maybe the most
mind -bending application. Visualizing molecules.
Ah, yes. Drug discovery at the atomic level.
This is where VR, especially, feels almost like
science fiction made real. How so? I mean, we
have computer models already. We do, but they're
often complex, maybe shown on a 2D screen. VR
lets researchers literally step inside the 3D
world of proteins and drug molecules. To step
inside a protein? Virtually, yes. Imagine seeing,
in immersive 3D, exactly how a potential drug
molecule fits into the binding site of a target
protein. You can walk around it, manipulate it,
see the atomic interactions up close. That sounds...
Incredible compared to just looking at a flat
image or rotating a model on screen. It's a completely
different level of intuition. You can feel the
spatial relationships. Remember our discussions
on structure -activity relationships. How 3D
shape is everything. Yeah, SAR is fundamental.
VR gives you an unprecedented way to understand
and leverage those 3D relationships when you're
designing a new drug. So this could really boost
rational drug design. Being able to visually
assess how changes to a molecule might affect
its fit. Precisely. You can see the binding site
more clearly. spot where modifications might
improve binding, maybe increase efficacy, or,
just as importantly, see where it might bind
incorrectly. Ah, like predicting off -target
effects. Potentially, yes. We talked about off
-target screening in preclinical work. Imagine
visualizing how your drug candidate might fit
into an unintended protein target in VR. That
could help design safer, more selective drugs
from the start. That's powerful. Avoiding problems
way downstream, it feels like it could open up
totally new ways to think about discovery. It
really could. And AR has a potential role here
too, sort of linking the virtual and the real
lab bench. How would that work? The idea mentioned
was overlaying these complex molecular models
onto your actual experimental setup in the lab.
So while you're doing an experiment, you could
see a 3D representation of the molecules you're
working with right there on your bench through
an AR display. Bridging the computational and
the lab work more directly. Exactly. Making it
a more integrated, maybe more intuitive research
process. Okay. Wow. So training, design, molecular
visualization. We've covered a lot of ground.
Let's maybe try and pull this together. What
are the big practical takeaways right now? And
what's the buzz about the future? Well, I think
the main takeaway is that this isn't just coming
soon tech anymore. It's actively being used.
VR and AR. are tools today in pharma training,
facility design, process optimization, and drug
discovery. And delivering real benefits. Seems
like it. Things like better efficiency, improved
safety, potential cost savings, and just a deeper
understanding, whether it's of a manufacturing
process or a molecular interaction. We've linked
it to avoiding issues like gelling, improving
GMP compliant through better training, and getting
new insights for drug design. And looking forward,
what's next? The potential for remote collaboration
seems huge. The transcript touched on this, experts
in different countries working together in a
shared virtual space. Like reviewing a plant
design together virtually. Or analyzing a molecule.
Exactly. That could seriously speed things up,
break down geographical barriers. Imagine combining
that with AI. using VRR as the interface to understand
complex AI -driven simulations or data analysis
in drug development. That sounds like a powerful
combination, a visual interactive way to grasp
what the AI is finding. Definitely. And then
there's communication and education more broadly.
How so? Think about explaining a complex drug
mechanism using VR or AR to show a doctor or
even a patient how a drug actually works in the
body visually. Wow, showing a patient their medication
working virtually, that could be huge for understanding
and maybe adherence. Enormous potential there.
better communication, better understanding all
around. It really is fascinating how these immersive
techs are moving into such a critical, regulated
field. Okay, so wrapping up this deep dive, it's
clear VR and AR aren't just, you know, novelties.
They seem to be genuinely changing how things
are done. Training, design, discovery. They really
are becoming integral tools. And it makes you
think, doesn't it, as these technologies get
even better, more immersive? It raises a really
interesting question. Go on. Well, with VR and
AR becoming so powerful at visualizing complex
data, simulating reality so closely? How might
that change our basic understanding of biology
itself? Could it lead to entirely new ways of
thinking about drug discovery, approaches we
haven't even dreamed of yet? That's a deep one
to end on. What new insights might emerge when
we can truly see biology in these new ways? A
lot to think about. OK, that's all the time we
have for this deep dive. Thanks for joining us.
Thanks, everyone. We'll explore another frontier
with you next time.